Embecta Corp. (EMBC )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol EMBC
- Company Embecta Corp.
- Price $4.42
- Changes Percentage 26.29
- Change 0.92
- Day Low $3.96
- Day High $4.69
- Year High $15.55
- Year Low $2.77
- Market Cap $214,469,552
- Price Avg 50 EMA (D) $3.24
- Price Avg 200 EMA (D) $9.03
- Exchange NASDAQ
- Volume 486,050
- Average Volume 2,585,429
- Open $4.14
- Previous Close $3.5
- EPS 2.6
- PE 1.39
- Earnings Announcement 2026-08-06 12:30:00
- Shares Outstanding $59,327,677
Company brief: EMBECTA CORP. (EMBC )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. Devdatt Kurdikar
- https://www.embecta.com
- US
- N/A
- 03-22-2022
- US29082K1051
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.